ScholarWorks@성균관대학교

상세 보기

Ifinatamab deruxtecan (I-DXd) in extensive-stage (ES) small cell lung cancer (SCLC): Asian subgroup analysis from the phase II IDeate-Lung01 study

Hayashi, H.;
Liu, Y.;
Nishio, M.;
Kim, Y. J.;
Sakai, T.;
외 12명

Citations

WEB OF SCIENCE

0

제목: Ifinatamab deruxtecan (I-DXd) in extensive-stage (ES) small cell lung cancer (SCLC): Asian subgroup analysis from the phase II IDeate-Lung01 study

저자: Hayashi, H.; Liu, Y.; Nishio, M.; Kim, Y. J.; Sakai, T.; Han, J-y.; Zhou, Q.; Ko, R.; Kim, D-w.; Wang, J.; Yang, J. c-h.; Hu, H.; Qian, M.; Goto, H.; Hirose, D.; Qian, L.; Ahn, M-j.

DOI: 10.1016/j.annonc.2025.10.636

발행일: 2025-12

유형: Meeting Abstract

저널명: Annals of Oncology

권: 36